Saudia Aramco Energy Ventures’s head pledges the Saudia Arabia-based energy company is looking to become “an integrated energy and chemicals company with greater energy efficiency and use of alternative energy.”
Month: February 2012
No stalling for Time Warner on Conviva
Media conglomerate Time Warner led a $15m investment in US-based video streaming technology company Conviva on Monday, through its corporate venturing fund, Time Warner Investments (TWI). The series D capital takes Conviva’s total funding to $59m since its launch in 2006, with backers also including venture capital firms New Enterprise Associates, GGV Capital and Pelion… Continue reading No stalling for Time Warner on Conviva
Boyer warns on biotech venture’s future
The founder of Genentech says the sector is the biggest “loss-maker” for VCs meaning a potential funding drought.
Dow Jones hires Fenwick from Bloomberg
The 25-year Bloomberg veteran, formerly the head of Bloomberg Ventures, has been hired by Dow Jones as its chief executive.
Google opens UK ‘university’
US-based search engine Google is reportedly set to unveil plans for an internet university designed to encourage entrepreneurship in the UK. The building will be based in 4 to 5 Bonhill Street near London’s technology cluster "Silicon Roundabout", according to UK news provider the Evening Standard yesterday. The so-called "Campus" will provide more than 100… Continue reading Google opens UK ‘university’
Mobeam cashes a further $1.5m
The mobile commerce company has topped up a series A round partly financed by Samsung and Mitsui to $6.4m.
Troika puts the pen down on Evernote
Investment bank Troika Dialog has divested its stake in online note taking company Evernote, garnering an exit ten times the size of its investment.
Rosenthal goes through the OpenX door
Digital advertising company OpenX, backed by several corporates, has hired Eric Rosenthal from investor AOL as the general manager of its Enterprise division.
Merck finds fertile ground in Auxogyn
Merck Serono, the biopharmaceutical division of pharmaceutical conglomerate Merck, has made an investment in the series A round for US-based reproductive health company Auxogyn through its corporate venturing fund, Merck Serono Ventures. The round closed on Thursday, with Auxogyn having raised $20m. Merck was joined in the round by TPG Biotech, the life sciences investment… Continue reading Merck finds fertile ground in Auxogyn
Merrimack to wait longer for IPO
The Fidelity-backed cancer drug developer has postponed its $191m IPO after setting the range, according to reports.
Goldman wins again with the social network
Goldman’s publicity coup as third underwriter of Facebook’s $5bn IPO
AVG secures $128m IPO
The computer security firm has raised $128m upon its flotation on NASDAQ, with Intel Capital garnering nearly $12m from the offering.
Samsung takes assets to $1.2bn
As part of its $400m fundraising from Samsung’s business units, which range from electronics to chemicals and heavy industry, SVIC has expanded its team and set aside part of the commitment to take seed-stage deals initially in the US.
KDDI starts venturing fund
The $65m KDDI Open Innovation Fund will invest in local and foreign companies and KDDI said it would also offer service development, platforms for cloud services using the phone operator’s Au Smart Pass content offering, and support for promotional activities.